Novavax (NVAX)
Add to Watchlists Create an Alert
2.05
+0.09 +4.59%
NASDAQ
May 22, 8:00PM
BATS Real time
Currency in USD
Novavax Book Value
Novavax Historical Book Value Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 80.24M |
| Sept. 30, 2012 | 61.38M |
| June 30, 2012 | 61.08M |
| March 31, 2012 | 54.32M |
| Dec. 31, 2011 | 53.85M |
| Sept. 30, 2011 | 54.60M |
| June 30, 2011 | 56.27M |
| March 31, 2011 | 53.53M |
| Dec. 31, 2010 | 59.05M |
| Sept. 30, 2010 | 66.99M |
| June 30, 2010 | 57.52M |
| March 31, 2010 | 63.14M |
| Dec. 31, 2009 | 69.95M |
| Sept. 30, 2009 | 67.02M |
| June 30, 2009 | 59.72M |
| March 31, 2009 | 37.79M |
| Dec. 31, 2008 | 45.49M |
| Sept. 30, 2008 | 56.13M |
| June 30, 2008 | 47.22M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Book Value of Equity
YCharts' book value of equity is the equivalent of total assets less total liabilities and preferred equity.
The book value of equity represents the equity of shareholders (from a balance sheet perspective) less the preferred stock.
Learn More
NVAX Book Value Benchmarks
| Companies | |
|---|---|
| Sinovac Biotech | 117.72M |
| Biocryst Pharmaceuticals | -2.84M |
| Hemispherx Biopharma | 44.70M |
NVAX Book Value Range, Past 5 Years
| Minimum | 37.79M | Mar 2009 |
| Maximum | 80.24M | Dec 2012 |
| Average | 58.17M |
